AI In Healthcare

Cranfield, UK, 25th April 2024 - Over $5.3 billion has been raised by medical...

23 April 2024, Investment into AI-based software across medical diagnostics and clinical care has been notably boom-or-bust in the last decade. Radiology has long been the “poster child” for funding and penetration of healthcare markets, with over $5.6B raised to date resulting in well-known successes such as Heartflow, viz.ai, annalise.ai and Ultromics.

Over the last 12 months, Signify Research has tracked generative AI (gen AI) product announcements in healthcare to understand the most prevalent use cases and those lacking traction.

This insight provides an overview of the key developments witnessed at HIMSS from our teams that were in attendance in Orlando earlier this month. The insight is broken down into four areas of the healthcare technology industry:

Medical imaging AI is increasingly included within radiology IT tenders, with imaging IT vendors needing to address how the integration of AI image analysis tools into the workflow will be achieved.

Signify Research’s Generative AI Market Intelligence Service delivers thorough analysis and a reliable product database, empowering decision-makers with insights into use cases and competitive vendors within the realm of generative AI capabilities in medical imaging.